Live Breaking News & Updates on European Medicines Agency

Stay updated with breaking news from European medicines agency. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cellectis Receives Orphan Drug Designation for UCART22, its Allogeneic CAR T Product for ...

NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell ....

United-states , Raleigh , North-carolina , Paris , France-general , France , New-york , American , Patricia-sosa-navarro , Pascalyne-wilson , Mark-frattini , Ashleyr-robinson

CStone's Sugemalimab Poised for European Approval

CStone's Sugemalimab Poised for European Approval
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

European-medicines-agency-committee-for-me , Cstone-pharmaceuticals , European-medicines-agency ,

AbbVie Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU

AbbVie Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Committee-for-medicinal-products-human-use , European-medicines-agency , Medicinal-products , Human-use ,

AbbVie Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU - AbbVie (NYSE:ABBV), ALX Oncology Holdings (NASDAQ:ALXO)

AbbVie (NYSE: ABBV) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending approval of Skyrizi (risankizumab) in the EU to treat adults with moderately to severely active ulcerative colitis (UC). ....

United-states , Abbvie-skyrizi , Annovis-bio , Boehringer-ingelheim , Abbvie-inc , Committee-for-medicinal-products-human-use , Entera-bio-ltd , European-medicines-agency , Oncology-holdings , Medicinal-products , Human-use , Zacks-rank

CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC

SUZHOU, China, June 2, 2024 /PRNewswire/ — CStone Pharmaceuticals (HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and… ....

China , Switzerland , United-kingdom , Suzhou , Jiangsu , Jason-yang , European-medicines-agency , Regulatory-agency , Committee-for-medicinal-products-human-use , Cstone-pharmaceuticals , European-commission , Drug-administration